We came across a bullish thesis on Teva Pharmaceutical Industries Limited (TEVA) on Kontra Investment Xchange’s Substack by ...
Total Revenues in the first nine months of 2024 increased by $300 million compared to same period in 2023, to $339 million, with Q3 revenues contributing $103 millionProduct revenues in the first nine ...
The collaboration between the two companies reflects ongoing efforts to enhance drug development, the CEO of Immunai said.
Germany has mandated its sales authority to work on the sale of Eurofighter Typhoon fighter jets to Turkey after initially ...
Turkey was offered partner country status by the BRICS group of nations, Trade Minister Omer Bolat said, as Ankara continues ...
Alvotech and Teva Pharmaceuticals announced that the U.S. FDA has approved ... Bangladesh and Pakistan), YAS Holding LLC ...
Teva Pharmaceutical ( (TEVA)) has provided an update. Teva Pharmaceutical Industries has appointed Chen Lichtenstein as a new independent Board member, effective December 1, 2024. With a robust ...
In a report released today, Balaji Prasad from Barclays maintained a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a price target of $25.00. The company’s shares closed last Friday ...